BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3447443)

  • 1. Membranes and their removal of uremic toxins.
    Hoenich NA
    Adv Exp Med Biol; 1987; 223():253-62. PubMed ID: 3447443
    [No Abstract]   [Full Text] [Related]  

  • 2. Separation and characterization of uremic metabolites in biologic fluids: a screening approach to the definition of uremic toxins.
    Gordon A; Berström J; Fürst P; Zimmerman L
    Kidney Int Suppl; 1975 Jan; (2):45-51. PubMed ID: 1057692
    [No Abstract]   [Full Text] [Related]  

  • 3. [Uremic middle-molecule toxins and their removal in hemofiltration].
    Kazakov IV; Timokhov VS
    Urol Nefrol (Mosk); 1991; (1):67-73. PubMed ID: 1858215
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medium-sized molecules and the process of uremic intoxication].
    Lutz W
    Pol Tyg Lek; 1976 Jul; 31(27):1173-6. PubMed ID: 951302
    [No Abstract]   [Full Text] [Related]  

  • 5. Replacement of excretory kidney function by high-efficiency hemodiafiltration (HDF) with a peptide-permeable membrane.
    Wizemann V; Techert F; Brüning S; Birk HW; Mueller K
    Adv Exp Med Biol; 1987; 223():263-6. PubMed ID: 3447444
    [No Abstract]   [Full Text] [Related]  

  • 6. Uremic toxins and peritoneal dialysis.
    Lameire N; Vanholder R; De Smet R
    Kidney Int Suppl; 2001 Feb; 78():S292-7. PubMed ID: 11169029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Uremic Toxins: how can we improve the removal today?].
    Teatini U; Romei Longhena G
    G Ital Nefrol; 2017 Sep; 34(5):89-101. PubMed ID: 28963830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The peritoneum as a dialysis membrane].
    Grzegorzewska A
    Pol Tyg Lek; 1984 Nov; 39(45):1493-7. PubMed ID: 6393092
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal versus continuous versus intermittent therapies for removal of uremic toxins.
    Clark WR; Henderson LW
    Kidney Int Suppl; 2001 Feb; 78():S298-303. PubMed ID: 11169030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uremic toxins: a new focus on an old subject.
    Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
    Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins.
    Ciceri P; Cozzolino M
    Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34073439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on uremic toxins.
    Ringoir S
    Kidney Int Suppl; 1997 Nov; 62():S2-4. PubMed ID: 9350668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choosing a membrane.
    Henderson LW; Cheung AK; Chenoweth DE
    Am J Kidney Dis; 1983 Jul; 3(1):5-20. PubMed ID: 6346867
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetics of solute removal in hemodialysis.
    Gotch FA
    Adv Exp Med Biol; 1987; 223():227-37. PubMed ID: 3328954
    [No Abstract]   [Full Text] [Related]  

  • 15. The fraction b 4-2: isolation, characterization and biological activities with reference to uremic polyneuropathy.
    Man NK; Cueille G; Faguer P; Boudet J; Pierrat D; Zingraff J; Sausse A; Funck-Brentano JL
    Adv Exp Med Biol; 1987; 223():135-40. PubMed ID: 3447428
    [No Abstract]   [Full Text] [Related]  

  • 16. Should dialysis modalities be designed to remove specific uremic toxins?
    Baurmeister U; Vienken J; Ward RA
    Semin Dial; 2009; 22(4):454-7. PubMed ID: 19709001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uremic toxicity: present state of the art.
    Vanholder R; Argilés A; Baurmeister U; Brunet P; Clark W; Cohen G; De Deyn PP; Deppisch R; Descamps-Latscha B; Henle T; Jorres A; Massy ZA; Rodriguez M; Stegmayr B; Stenvinkel P; Wratten ML
    Int J Artif Organs; 2001 Oct; 24(10):695-725. PubMed ID: 11817319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urea and uremic solutes: how does peritoneal dialysis work?
    Bammens B
    Semin Nephrol; 2011 Mar; 31(2):127-37. PubMed ID: 21439427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do we need new indicators of dialysis adequacy based on middle-molecule removal?
    Vanholder R; Eloot S; Van Biesen W
    Nat Clin Pract Nephrol; 2008 Apr; 4(4):174-5. PubMed ID: 18268526
    [No Abstract]   [Full Text] [Related]  

  • 20. History of sorbents in uremia.
    Winchester JF; Ronco C; Brady JA; Clemmer J; Muller TE; Davankov V; Tsyurupa M; Pavlova L; Pavlov M; Levin NW
    Contrib Nephrol; 2001; (133):131-9. PubMed ID: 11477746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.